US biochemist researching treatment of HIV and coronaviruses wins Israel’s Wolf Prize
An American biochemist whose research has helped scientists make inroads on treating coronavirus and HIV has won this year’s ...
Tech Explorist5d
Breakthrough antibody therapies offer hope for HIV treatment
Researchers from Imperial College London, working with the University of Oxford and Rockefeller University, have shown ...
Gilead Presents New HIV Treatment And Cure Research Data
Gilead's CROI 2025 data highlights Biktarvy's sustained HIV/HBV suppression, lenacapavir's efficacy, and vesatolimod's safety ...
Amsterdam News6dOpinion
OP-ED: Prioritizing Women for HIV Prevention and Treatment
The U.S. faces an ongoing HIV epidemic, with women, particularly women of color, bearing a heavy burden. While there have ...
HIV's latent reservoir: New insights into Nef protein offer potential strategy to improve treatment
A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...
“Magic” for Those Who Can’t Take Pills: Groundbreaking HIV Treatment Achieves 98% Viral Suppression
UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...
Applied Clinical Trials Online3d
Doravirine/Islatravir Regimen Shows Promise in Multiple Phase III Trials for the Treatment of HIV
The combination demonstrated non-inferiority to comparator antiretroviral therapies, meeting the primary efficacy success ...
Morningstar4d
Gilead Presents New HIV Treatment and Cure Research Data at CROI 2025, Including an Investigational Long-Acting, Twice-Yearly Therapy Option
“Our contributions to CROI spotlight our dedication to scientific discovery, reflect our commitment to addressing the diverse treatment needs and preferences of communities affected by HIV and ...
Morningstar6d
Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025
Such ‘regained’ post-treatment control may be associated with an immune response to the virus. There was also a reduction in CD4+ T cell-associated HIV Gag RNA in some PLWH during treatment ...
Montgomery Advertiser on MSN2d
Alabama still fighting HIV: 'In the South is where we have the majority of the problems':
Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...
Healio2d
Long-acting treatment benefits postpartum women with HIV and their babies
Switching to long-acting ART from oral treatments was cost effective for postpartum women with HIV and improved infant outcomes, researchers said at the Conference on Retroviruses and Opportunistic ...